ESSPRI
Showing 1 - 25 of 75
Sjögren and Gynecologic Considerations
Completed
- Primary Sjögren Syndrome
- +3 more
- Visual analogue scale (VAS) for dyspareunia
- +3 more
-
Ankara, TurkeyAnkara City Hospital
Jan 3, 2023
Dry Eye Syndrome, Xerophthalmia Trial (Acupuncture, Oral microbiota, Schirmer's test)
Recruiting
- Dry Eye Syndrome
- Xerophthalmia
- Acupuncture
- +14 more
-
Taipei, TaiwanChing-Mao Chang
Dec 11, 2022
Sjogren's Syndrome, Fatigue, Pain Syndrome Trial in Yildirim (FACT-F questionnaire, Beck Depression Inventory, Beck Anxiety
Completed
- Sjogren's Syndrome
- +5 more
- FACT-F questionnaire
- +6 more
-
Yıldırım, Bursa, TurkeyKoray Ayar
Nov 29, 2021
Objective Measurement With TCM Pattern for AIDDES
Recruiting
- Sjögren's Syndrome
- +2 more
- Traditional Chinese Medicine pattern
- +6 more
-
Taipei, TaiwanChing-Mao Chang
May 4, 2021
Sjogren's Syndrome Trial in Beijing (Baricitinib, Hydroxychloroquine)
Recruiting
- Sjogren's Syndrome
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 17, 2022
Sjogren's Syndrome Trial (Anifrolumab)
Recruiting
- Sjogren's Syndrome
- Anifrolumab
- Placebo
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Dec 16, 2022
Dry Eye Syndrome, Sjogren's Syndrome, Xerophthalmia Trial in Taipei (Chinese herbal tea VGH-DESJS-1)
Not yet recruiting
- Dry Eye Syndrome
- +2 more
- Chinese herbal tea VGH-DESJS-1
-
Taipei, TaiwanChing-Mao Chang
Dec 19, 2022
Primary Sjögren's Syndrome Trial (Efgartigimod, Placebo)
Not yet recruiting
- Primary Sjögren's Syndrome
- Efgartigimod
- Placebo
- (no location specified)
Apr 5, 2023
Sjogrens Syndrome Trial (Ianalumab (VAY736), Placebo)
Not yet recruiting
- Sjogrens Syndrome
- Ianalumab (VAY736)
- Placebo
- (no location specified)
Aug 3, 2023
Sjogren Syndrome With Other Organ Involvement Trial (Hydroxychloroquine, Tacrolimus)
Not yet recruiting
- Sjogren Syndrome With Other Organ Involvement
- (no location specified)
Dec 28, 2022
Sjogren Syndrome With Other Organ Involvement Trial (Prednisolone, Tacrolimus)
Not yet recruiting
- Sjogren Syndrome With Other Organ Involvement
- (no location specified)
Jan 12, 2023
Primary Sjögren Syndrome Trial in Rochester (Ustekinumab)
Completed
- Primary Sjögren Syndrome
-
Rochester, New YorkUniversity of Rochester
Jul 6, 2022
Sjögren's Syndrome Trial in Worldwide (Deucravacitinib, Placebo)
Not yet recruiting
- Sjögren's Syndrome
- Deucravacitinib
- Placebo
-
Santa Monica, California
- +25 more
Jul 19, 2023
Primary Sjogren's Syndrome Trial in Palo Alto (tibulizumab (LY3090106))
Withdrawn
- Primary Sjogren's Syndrome
- tibulizumab (LY3090106)
-
Palo Alto, CaliforniaStanford University
Jan 12, 2022
Primary Sjögren's Syndrome Trial in Hangzhou (Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets)
Recruiting
- Primary Sjögren's Syndrome
- Iguratimod Tablets
- Hydroxychloroquine Sulfate Tablets
-
Hangzhou, Zhejiang, ChinaSecond affiliated hospital of zhejiang university,school of medi
Mar 23, 2022
Intestinal Microbiota in Gougerot-Sjögren Syndrome According to
Recruiting
- Sjogren's Syndrome
- Biomarker detection
-
Nîmes, FranceCHU de Nimes
May 24, 2022
Sjogren's Syndrome Trial in Worldwide (Placebo, Nipocalimab, Standard of Care Treatment)
Recruiting
- Sjogren's Syndrome
- Placebo
- +2 more
-
Anniston, Alabama
- +77 more
Aug 18, 2022
Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)
Recruiting
- Primary Sjögren's Syndrome
-
Beijing, Beijing, ChinaDepartment of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022
Sjögren Syndrome, Sicca Syndrome Trial in São Paulo (N-acetylcysteine syrup, Placebo syrup)
Active, not recruiting
- Sjögren Syndrome
- Sicca Syndrome
- N-acetylcysteine syrup
- Placebo syrup
-
São Paulo, Sao Paulo, Brazil
- +1 more
Jun 13, 2022
Primary Sjögren's Syndrome Trial in Worldwide (S95011 concentrate for solution for infusion, Placebo concentrate for solution
Active, not recruiting
- Primary Sjögren's Syndrome
- S95011 concentrate for solution for infusion
- Placebo concentrate for solution for infusion
-
Beverly Hills, California
- +27 more
Jan 13, 2023
Sjogren's Syndrome Trial in Beijing (Baricitinib 2 MG)
Completed
- Sjogren's Syndrome
- Baricitinib 2 MG
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 26, 2021
Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Completed
- Small Fiber Neuropathy
- Primary Sjögren Syndrome
- cutaneous silent period (CSP) measurement
-
Istanbul, Pendik, TurkeyMarmara University Pendik Education and Research Hospital
May 16, 2022
Sjogren Syndrome, Mixed Connective Tissue Disease Trial in Worldwide (MHV370, Placebo)
Recruiting
- Sjogren Syndrome
- Mixed Connective Tissue Disease
- MHV370
- Placebo
-
Guangzhou, Guangdong, China
- +18 more
Jul 29, 2022